Giuliani M

No ORCID on file · 4 papers in corpus
observational 2026
Ten years of DuoStim in time-sensitive poor-prognosis IVF patients: real world cumulative outcomes and treatment trajectories
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1854570

AIMS: To evaluate DuoStim strategy across a decade from its clinical implementation in IVF by comparing embryological and clinical outcomes between the first and second ovarian stimulations (1st-OS and 2nd-OS) conducted within 30 days, focu…

observational 2025
A multicycle approach through DuoStim with a progestin-primed ovarian stimulation (PPOS) protocol: a valuable option in poor prognosis patients undergoing PGT-A
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03317-0

PURPOSE: This study is to evaluate the effectiveness of a PPOS protocol in poor prognosis patients undergoing IVF with DuoStim and PGT-A versus the conventional protocol with GnRH antagonist. METHODS: Retrospective cohort study encompassin…

observational 2025
A standardized training allows achieving similar clinical pregnancy rates per top-quality euploid blastocyst transfer across operators
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03396-7

PURPOSE: To evaluate the performance of different embryo transfer (ET) operators in a strictly controlled scenario minimizing potential confounders. METHODS: This single-center retrospective cohort study analyzed vitrified-warmed single eu…

other 2022
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02409-z

PURPOSE: Our primary objective was to assess whether immediately undergoing a second stimulation in the same ovarian cycle (DuoStim) for advanced-maternal-age and/or poor-ovarian-reserve (AMA/POR) patients obtaining ≤ 3 blastocysts for prei…